Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis-Reference-Cited by-同舟云学术

Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis

Published:2004-12 Issue:12 Volume:24 Page:2211-2218
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Khalil Maged F.¹,Wagner William D.¹,Goldberg Ira J.¹

Affiliation:

1. From the Division of Preventive Medicine & Nutrition (M.F.K., I.J.G.), Columbia University College of Physicians & Surgeons, New York, NY; and the Department of Pathology (W.D.W.), Wake Forest University School of Medicine, Winston-Salem, NC.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference94 articles.

1. Vogel J. 1854. The Pathological Anatomy of Human Body. London: H. Balliere; 1854.

2. Lipoproteins, Coronary Heart Disease, and Atherosclerosis

3. Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts

4. Myant N. Cholesterol and atherosclerosis. London: Williams Heinemann; 1981: 68.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Lipoprotein(a) Levels as a Predictor of Aortic Stiffness in Patients on Long-Term Peritoneal Dialysis;Medical Science Monitor;2024-04-19

2. Extracellular Matrix Interactome in Modulating Vascular Homeostasis and Remodeling;Circulation Research;2024-03-29

3. Mechano-chemo-biological model of atherosclerosis formation based on the outside-in theory;Biomechanics and Modeling in Mechanobiology;2023-12-23

4. Connecting the Dots: How Injury in the Arterial Wall Contributes to Atherosclerotic Disease;Clinical Therapeutics;2023-11

5. The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications;Cells;2023-09-19